Ocular Therapeutix

Link: http://www.ocutx.com

OCULAR THERAPEUTIX EYE DRUG FAILS SECOND STUDY 

7 Apr 2015   | PharmaBusiness Daily

Ocular Therapeutix says its lead eye drug failed to meet one of the main goals in a second late-stage study, Reuters reports.

The drug, OTX-DP, was effective in reducing pain in patients who had cataract surgery, but failed to reduce the inflammation in the eyes, the company said.

Both endpoints needed to be met for the trial to be considered successful, Ocular Therapeutix said.

Ocular Therapeutix said in March that the drug reduced pain and inflammation in patients in a first late-stage trial.